These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1966355)

  • 1. Role of insulin receptors in the expression of prostaglandin E1 binding activity in platelets.
    Kahn NN; Sinha AK
    Adv Exp Med Biol; 1990; 281():271-6. PubMed ID: 1966355
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase.
    Kahn NN; Sinha AK
    J Biol Chem; 1990 Mar; 265(9):4976-81. PubMed ID: 1969414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets.
    Dutta-Roy AK; Kahn NN; Sinha AK
    Life Sci; 1991; 49(16):1129-39. PubMed ID: 1654491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans.
    Kahn NN; Bauman WA; Hatcher VB; Sinha AK
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2160-7. PubMed ID: 8285255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia.
    Kanof PD; Davidson M; Johns CA; Mohs RC; Davis KL
    Am J Psychiatry; 1987 Dec; 144(12):1556-60. PubMed ID: 2825548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1991 Jan; 68(1):245-54. PubMed ID: 1845854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desacetyl-1-nantradol: a selective prostaglandin antagonist.
    Horne WC
    Prostaglandins Leukot Med; 1984 Jul; 15(1):129-36. PubMed ID: 6147860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1990 Apr; 66(4):932-40. PubMed ID: 2156636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 14. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: isoproterenol and prostaglandin E1-stimulated cyclic AMP accumulation in lymphocytes.
    Ebstein RP; Oppenheim G; Stessman J
    Life Sci; 1984 Jun; 34(23):2239-43. PubMed ID: 6145077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin and prostaglandin E1: molecular mechanisms and therapeutic utility.
    Kerins DM; Murray R; FitzGerald GA
    Prog Hemost Thromb; 1991; 10():307-37. PubMed ID: 1848945
    [No Abstract]   [Full Text] [Related]  

  • 17. Human prostacyclin receptor: cloning and co-expression with EP3 prostaglandin receptor.
    Ortiz-Vega S; Ashby B
    Adv Exp Med Biol; 1997; 433():235-8. PubMed ID: 9561143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Potentiation by phorbol ester, a protein kinase activator, of the effect of prostaglandin E1 on human platelets].
    Avdonin PV; Bugriĭ EM; Tkachuk VA; Mazaev AV
    Dokl Akad Nauk SSSR; 1986; 286(3):746-9. PubMed ID: 3004871
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin-induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury.
    Kahn NN; Bauman WA; Sinha AK
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):245-9. PubMed ID: 8552614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.